Ashley Richards, PharmD, BCOP
Ashley Richards, PharmD, BCOP, is a clinical specialist in hematologic malignancies and hematologic stem cell transplant at UF Health Shands Hospital and director of the PGY2 Oncology Pharmacy Residency.
Dr. Richards received her Doctor of Pharmacy from the University of Florida College of Pharmacy before completing a pharmacy practice residency at UF Health Jacksonville in 2008. She then completed an oncology specialty pharmacy residency at the University of Washington Medical Center/Seattle Cancer Care Alliance in Seattle, Washington. Her areas of interest are leukemia and bone marrow transplantation, as well as sarcoma. Dr. Richards is also a clinical assistant professor of the University of Florida College of Pharmacy and preceptor for pharmacy students and residents.
Sarah Wheeler, PharmD, BCPS, BCOP
Sarah Wheeler, PharmD, BCPS, BCOP, is a clinical specialist in blood and marrow transplantation at UF Health Shands Hospital and a clinical assistant professor at the University of Florida College of Pharmacy. Dr. Wheeler received her Doctor of Pharmacy from the University of Florida College of Pharmacy and completed her PGY1 pharmacy residency and PGY2 oncology specialty residency at Emory University Hospital. She is an active member of the Hematology/Oncology Pharmacy Association.
Her areas of interest include acute promyelocytic leukemia, immunotherapy and the effect it has on drug metabolism, and prophylaxis and treatment of graft versus host disease.
C. Brooke Adams, PharmD, BCOP
Brooke Adams, PharmD is a clinical pharmacy specialist in blood and marrow transplantation at UF Health Shands Hospital and a clinical assistant professor at the University of Florida College of Pharmacy. After receiving her Doctor of Pharmacy with research concentration from East Tennessee State University, Dr. Adams went on to complete her PGY1 pharmacy residency and PGY2 oncology specialty residency at Indiana University Health in Indianapolis, Indiana. Dr. Adams remains an active member of the Hematology/Oncology Pharmacy Association and American Society of Blood and Marrow Transplantation.
Her areas of interest include next generation sequencing utilization to guide therapeutic optimization based on genomic aberration, infectious disease complications post-transplantation, and management of graft versus host disease.